PT - JOURNAL ARTICLE AU - Khairnar, Krishna AU - Tomar, Siddharth Singh TI - Saline gargle-based SARS-CoV-2 genome surveillance for remote and rural setup with projections for post-pandemic monitoring AID - 10.1101/2023.02.16.23286031 DP - 2023 Jan 01 TA - medRxiv PG - 2023.02.16.23286031 4099 - http://medrxiv.org/content/early/2023/02/18/2023.02.16.23286031.short 4100 - http://medrxiv.org/content/early/2023/02/18/2023.02.16.23286031.full AB - Voluntary participation of the public in disease surveillance can be encouraged by deploying user-friendly sample collection processes that can minimise the discomfort to the participants. To increase sample collection throughput and reduce patient discomfort, the Council of Scientific and Industrial Research-National Environmental Engineering Research Institute (CSIR-NEERI) developed a non-invasive, patient-friendly saline gargle sample collection method for detecting the SARS-CoV-2 virus. This method can also be deployed for other respiratory viruses. This study evaluated the suitability of saline gargle-based sample collection for genomic surveillance of SARS-CoV-2. This study included 589 SARS-CoV-2 positive samples collected using the Gargle-based sample collection method from Nagpur city in central India from March to December 2021. The viral RNA was isolated from saline gargle samples using an RNA release buffer followed by SARS-CoV-2 RTPCR. The SARS-CoV-2 positive samples were subjected to SARS-CoV-2 whole genome sequencing using the oxford nanopore technologies (ONT) next-generation sequencing platform. Out of 589 samples, 500 samples qualified for the SARS-CoV-2 WGS, and the SARS-CoV-2 WGS results revealed 8 different clades of SARS-CoV-2 encompassing 37 different Pango-lineage types. Our findings indicate that non-invasive gargle-based genomic surveillance is scalable and does not need significant changes to the existing workflow post-sample collection. This makes it advantageous for underdeveloped or remote areas as a reliable and high-throughput sample collection; and a technique of choice for surveillance in post-pandemic scenarios, which can find more user acceptance than the invasive swab-VTM sample collection method.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported and funded by CSIR-NEERI, Nagpur.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Council of Scientific and Industrial Research-National Environmental Engineering Research Institute (CSIR-NEERI), Nagpur, India. Institutional Ethics Committee (IEC)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors